References
- Brittain R. T., Levy G. P. A review of the animal pharmacology of labetalol, a combined α- and β-adrenoceptor blocking drug. Br. J. clin. Pharmac. 1976; 3, Suppl. 681
- Brogden R. N., Heel R. C., Speight T. M., Avery Prazosin G. S. A review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs 1977; 14: 163
- Cavero I., Fenard S., Gomeni R., Lefevre F., Roach A. G. Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur. J. Pharmac. 1978; 49: 259
- Johnson G. L., Prioli N. A., Ehrreich S. J. Antihypertensive effects of labetalol (SCH 15719W, AH5158A). Fed. Proc. 1977; 36: 1049
- Martin L. E., Hopkins R., Bland R. Metabolism of labetalol by animals and man. Br. J. clin. Pharmac. 1976; 3, Suppl., 695
- Plummer A. J., Trapold J. H., Schneider J. A., Maxwell R. A., Earl A. E. Ganglionic blockade by a new bisquarternary series including chlorisondamine dimethochloride. J. Pharmac. exp. Ther. 1955; 115: 172
- Popovic V., Popovic P. Permanent cannulation of aorta and vena cava in rats and ground squirrels. J. appl. Physiol. 1960; 15: 727
- Richards D. A., Tuckman J., Prichard B. N. C. Assessment of α- and β-adrenoceptor blocking actions of labetalol. Br. J. clin. Pharmac 1976; 3: 849
- Richards D. A., Maconochie J. G., Bland R. E., Hopkins R., Woodings E. P., Martin L. E. Relationship between plasma concentrations and pharmacological effects of labetalol. Eur. J. clin. Pharmac. 1977; 11: 85
- Shirley E. A non-parametric equivalent of William's test for contrasting increasing dose-levels of a treatment. Biometrics 1977; 33: 386
- Sturtevant F. M. The biology of metacorticoid hypertension. Ann. Int. Med. 1958; 49: 1281